Primary Care Clinical Focus
Infection Control & Resistance Management
Bacterial infections require robust, resistance-shielded anti-infectives. Our co-amoxiclav formulation (KONFYL-625) pairs Amoxicillin with Potassium Clavulanate to neutralize bacterial beta-lactamase defenses, ensuring high clinical clearance rates.
Gastric Acid & Motility Suppression
Acid-related gastrointestinal issues demand dual-action control. By combining a proton pump inhibitor with a prokinetic, gastric acidity is lowered while gastric transit is accelerated, resolving both heartburn and nausea.